TIL

32.24

8.66% 2.57

Dopo l'orario di chiusura: 32.05 -0.19 -0.59%

Instil Bio Inc (TIL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$29.67

Aprire:

$29.7

Volume 24 ore:

219.53K

Relative Volume:

0.68

Capitalizzazione di mercato:

$211.46M

Reddito:

Utile/perdita netta:

$-74.14M

Rapporto P/E:

-2.8306

EPS:

-11.39

Flusso di cassa netto:

$-65.70M

1 W Prestazione:

+16.39%

1M Prestazione:

+13.00%

6M Prestazione:

+37.57%

1 anno Prestazione:

+152.07%

Intervallo 1D:

$29.51

$32.76

Intervallo di 1 settimana:

$25.58

$32.76

Portata 52W:

$9.85

$92.00

Instil Bio Inc Stock (TIL) Company Profile

Nome

Instil Bio Inc

Settore

Healthcare (1161)

Industria

Biotechnology (651)

Telefono

(972) 499-3350

Indirizzo

3963 MAPLE AVENUE, DALLAS

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

TIL's Discussions on Twitter

Confronta TIL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TIL Instil Bio Inc	32.24	194.63M	0	-74.14M	-65.70M	-11.39
VRTX Vertex Pharmaceuticals Inc	472.27	120.73B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	564.64	61.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	328.00	42.46B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	591.74	35.22B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	296.46	31.99B	3.81B	-644.79M	-669.77M	-6.24

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-07	Aggiornamento	Jefferies	Hold → Buy
2024-11-04	Iniziato	JMP Securities	Mkt Perform
2024-04-12	Downgrade	Jefferies	Buy → Hold
2022-11-01	Downgrade	Cowen	Outperform → Market Perform
2022-11-01	Downgrade	Truist	Buy → Hold
2021-08-13	Iniziato	Robert W. Baird	Outperform
2021-04-13	Iniziato	Cowen	Outperform
2021-04-13	Iniziato	Morgan Stanley	Equal-Weight
2021-04-13	Iniziato	Truist	Buy

Mostra tutto

Instil Bio Inc Borsa (TIL) Ultime notizie

Jul 24, 2025

Can Instil Bio Inc. stock recover from recent declineRecord-breaking capital gains - jammulinksnews.com

Jul 24, 2025

Should I buy Instil Bio Inc. stock before earningsRecord-breaking gains - jammulinksnews.com

Jul 24, 2025

Jul 22, 2025

What drives Instil Bio Inc. stock priceExceptional portfolio growth - jammulinksnews.com

Jul 22, 2025

Instil Bio Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com

Jul 22, 2025

What analysts say about Instil Bio Inc. stockFree Investment Portfolio Suggestions - Autocar Professional

Jul 22, 2025

Is Instil Bio Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Will Instil Bio Inc. stock benefit from interest rate changesSolid Return Trade Selections - Newser

Jul 20, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025

Jul 18, 2025

When is the best time to buy Instil Bio Inc. stockEntry Level Low Risk Picks - Newser

Jul 18, 2025

Jul 15, 2025

Why Instil Bio Inc. stock attracts strong analyst attentionProtected Capital Trading Plan - Newser

Jul 15, 2025

What makes Instil Bio Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025

How Instil Bio Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application - Investing.com

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application By Investing.com - Investing.com UK

Jul 02, 2025

Instil Bio, Inc. Announces U.S. F.D.A. Clearance of Investigational New Drug Application for AXN-2510 - MarketScreener

Jul 02, 2025

FDA clears Instil Bio’s IND for AXN-2510 cancer therapy - Investing.com

Jul 02, 2025

Jun 30, 2025

Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha

Jun 30, 2025

Jun 20, 2025